NCT00858624

Brief Summary

A cough lasting more than 2 months is known as a chronic cough, affecting 12-23% of the adult non-smoking population. Chronic cough has many associated complications including incontinence, muscular chest pains, blackouts and depression. Current treatment is often ineffective in these patients. To develop new medications the investigators need to understand more about the mechanisms that can lead to excessive coughing. This study plans to compare a group of 12 healthy volunteers and 12 patients with a chronic cough. The investigators hypothesise that that chronic cough patients have a more sensitive cough reflex as a result central nervous system hyper-excitability (central sensitisation). The investigators will measure cough reflex sensitivity before and after administration of ketamine, a medication that blocks an important receptor in the central nervous system.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Feb 2008

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2008

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

March 9, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 10, 2009

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2009

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2009

Completed
Last Updated

June 19, 2013

Status Verified

June 1, 2013

Enrollment Period

1.4 years

First QC Date

March 9, 2009

Last Update Submit

June 17, 2013

Conditions

Keywords

CoughCough reflexNMDA receptorcentral sensitisation

Outcome Measures

Primary Outcomes (1)

  • Cough Reflex Sensitivity

    6 months

Secondary Outcomes (3)

  • Upper Oesophageal Pain Thresholds

    6 months

  • Pain Thresholds Pharynx

    6 months

  • Pain Thresholds Chest Wall

    6 months

Study Arms (2)

Chronic Cough Patients

ACTIVE COMPARATOR
Drug: ketamine

Healthy Volunteers

ACTIVE COMPARATOR
Drug: ketamine

Interventions

Administration of low dose intravenous ketamine. Dose: 0.075mg/kg over 10 minutes followed by 0.005mg/kg/min over 20 minutes. Given as single infusion.

Chronic Cough PatientsHealthy Volunteers

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Healthy Volunteers:
  • Over 18 years old
  • Measurable cough reflex sensitivity
  • No current or past history of chronic cough or chronic respiratory disease.
  • No symptoms of gastro-oesophageal reflux disease, asthma or post-nasal drip.
  • Chronic Cough Patients
  • Over 18 years old
  • Chronic persistent cough (\> 8 weeks) despite investigation and/or treatment trials for cough variant asthma/post nasal drip and gastro-oesophageal reflux disease.
  • Normal CXR
  • Normal lung function
  • Measurable cough reflex sensitivity

You may not qualify if:

  • Recent Upper Respiratory Tract Infection (4 weeks)
  • Pregnancy/breast feeding
  • Current smokers or ex-smokers with \< 6 months abstinence or cumulative history of \> 10 packyears
  • Diabetes Mellitus
  • Opiate or ACE Inhibitor use.
  • Any centrally acting medication which has the potential to alter cough reflex sensitivity.
  • Significant and ongoing chronic respiratory, cardiovascular (in particular hypertension), gastro-intestinal, haematological (porphyria), neurological or psychiatric illness.
  • Drug or alcohol abuse
  • History of allergy or reaction to ketamine of other NMDA receptor antagonists.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Manchester, Education and Research Centre, Wythenshawe Hospital

Manchester, Manchester, M23 9LT, United Kingdom

Location

MeSH Terms

Conditions

Chronic CoughCough

Interventions

Ketamine

Condition Hierarchy (Ancestors)

Respiration DisordersRespiratory Tract DiseasesSigns and Symptoms, RespiratorySigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

CyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicHydrocarbonsOrganic Chemicals

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Reader

Study Record Dates

First Submitted

March 9, 2009

First Posted

March 10, 2009

Study Start

February 1, 2008

Primary Completion

July 1, 2009

Study Completion

July 1, 2009

Last Updated

June 19, 2013

Record last verified: 2013-06

Locations